Several cellular signaling pathways are dysregulated in CRC, including the unfolded protein response (UPR) and the antioxidant pathway, regulated by nuclear factor erythroid 2-related factor 2 (NRF2), leading to cancer onset, progression, and eventually chemoresistance [13,14]. This evidence concerns the gene NFE2L2 and cancer.